UPDATE: Goldman On Haloyzme Notes Co. 'is further de-risked, in that Enhanze is a proven technology: HALO has nine partnerships with top biopharma (including Roche, JNJ, ARGX, and ALXN) for it, and Enhanze is already used in three approved products'

'with a fourth, JNJ/GMAB’s Darzalex SC, pending approval'

Benzinga · 01/08/2020 18:40

'with a fourth, JNJ/GMAB’s Darzalex SC, pending approval'